Shanghai Hongxiang Yixintang Pharmaceutical Co., Ltd. announced that it will receive CNY 10,000,000 in an equity round of funding on February 8, 2018. The transaction will include participation from returning investor Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727). The company's registered capital will increase from CNY 5,000,000 to CNY 15,000,000. The transaction was approved from board of directors in its 5th session of the company’s 4th directorate.